Filing Details
- Accession Number:
- 0000874015-12-000041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-03 20:06:06
- Reporting Period:
- 2012-07-01
- Filing Date:
- 2012-07-03
- Accepted Time:
- 2012-07-03 19:06:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1073387 | Frank C Bennett | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Svp, Antisense Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-07-01 | 648 | $6.13 | 1,277 | No | 5 | J | Direct | |
| Common Stock | Acquisiton | 2012-07-03 | 6,000 | $6.84 | 7,277 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-03 | 6,000 | $12.91 | 1,277 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | J | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock' | Employee Stock Option (right to buy) | Disposition | 2012-07-03 | 6,000 | $0.00 | 6,000 | $6.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,500 | 2007-01-02 | 2013-01-01 | No | 4 | M | Direct |
Footnotes
- Reporting 648 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2012. These 648 shares may not be sold until January 2, 2013.
- Acquired as a result of exercising a stock option that was scheduled to expire on1/1/2013. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 6/19/2012.
Billionaire Hedge Funds
